Hope on the horizon: Wharton's jelly mesenchymal stem cells in the fight against COVID-19
Regen Med
.
2023 Sep;18(9):675-678.
doi: 10.2217/rme-2023-0077.
Epub 2023 Aug 9.
Authors
Gaurav Gupta
1
2
,
Md Sadique Hussain
3
,
Riya Thapa
1
,
Rajiv Dahiya
4
,
Debarshi Kar Mahapatra
5
,
Asif Ahmad Bhat
1
,
Neelam Singla
1
,
Vetriselvan Subramaniyan
6
,
Sushama Rawat
3
,
Vikas Jakhmola
7
,
Roshan S
8
,
Kamal Dua
9
10
Affiliations
1
School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India.
2
Center for Global Health research (CGHR), Saveetha Institute of Medical & Technical Science (SIMATS), Saveetha University, Chennai, India.
3
School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, Rajasthan, India.
4
School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, Saint Augustine, Trinidad & Tobago.
5
Department of Pharmaceutical Chemistry, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune 411018, Maharashtra, India.
6
Department of Pharmacology, Jeffrey Cheah School of Medicine & Health Sciences, MONASH University, Malaysia.
7
Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India.
8
Deccan School of Pharmacy, Hyderabad, India.
9
Faculty of Health, Australian Research Centre in Complementary & Integrative Medicine, University of Technology, Sydney, Ultimo-NSW 2007, Australia.
10
Discipline of Pharmacy, Graduate School of Health, University of Technology, Sydney, Ultimo-NSW 2007, Australia.
PMID:
37554111
PMCID:
PMC10411327
DOI:
10.2217/rme-2023-0077
No abstract available
Keywords:
COVID-19; mesenchymal stem cells; tissue regeneration.
Publication types
Editorial
MeSH terms
COVID-19* / therapy
Cell Differentiation
Humans
Mesenchymal Stem Cells*
Umbilical Cord
Wharton Jelly*